. . . . . "LDL" . . . "cholesterol" . . . "Atorvastatin" . . . "Statins" . "statins" . . . "dyslipidemia" . . . "CVD" . "cardiovascular diseases" . . . . . . . . . . . . . . . . . . . . . . . "2022-10-13T12:35:21.230396"^^ . . " Atorvastatin and other statins are considered first-line treatment options for dyslipidemia. The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels) is a significant risk factor for the development of CVD. Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a" . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "F40zk/co0p7hBtTcctGxpo+87Kg8Pd7CDOQb+Tac/oMtc9OlspkxUU2hfzi4VHm7CTLhhz2Ag0EcNNbVUKwvDCDOZtLvZWXNQkF/SoNQR9vQkaShAOmVndQtccuOzE/NugmJXRIqKxbYjajt9QSDNx3mdoO/lb9vMZBU/WTx+DaeFJnTxa6DfUAdCGsif/TIRu3QQtaQBaZhYWHRgFiUYLlzgTqi/eQdcjDF06zk1r1PJ3N42+Bpetsk6Ji5xJFh122slp+ZhEr3MAOJz+ddQtQpAt63QtXBjBSaz9upcWz33C8o7MK73uvt1uJ0BZV5t519NVzy/UPOGbpjN7afjg==" . . "2022-10-13T12:35:21.230396"^^ . .